secwatch.observer — SEC 8-K summary
======================================

Issuer:     LifeStance Health Group, Inc. (LFST)
CIK:        0001845257
Form:       8-K
Filed at:   2023-05-10T23:59:59+00:00
Accession:  0000950170-23-019901
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

LifeStance Q1 rev $252.6M (+24% YoY), net loss narrows to $34.2M; raises FY rev guidance
--------------------------------------------------------------------------------

- Revenue $252.6M (+24% YoY); Center Margin $69.6M (27.6% of revenue, +28% YoY).
- Net loss $34.2M vs $62.3M loss; Adj EBITDA $10.1M vs $12.5M (down 19%).
- FY 2023 revenue guidance raised to $990M-$1.02B; Center Margin $274-$290M; Adj EBITDA reaffirmed $50-$62M.
- Q2 2023 guidance: rev $250-$260M, Center Margin $69-$76M, Adj EBITDA $10-$16M.
- Clinicians 5,961 (+19% YoY, net add 330); cash $68.3M, net debt $224.8M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1845257/000095017023019901/0000950170-23-019901-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1845257/000095017023019901/lfst-20230510.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-019901

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer